Announced
Completed
Financials
Sources
Tags
France
Minority
Friendly
Acquisition
Completed
Cross Border
bio-pharmaceutical
Biotechnology
Private Equity
Private
Venture Capital
Synopsis
Private equity firm Perceptive Advisors led a $55m Series C Funding Round in Dynacure, a bio-technology company. Additional investors include Tekla Capital Management, Andera Partners, Bpifrance, Kurma Partners and Pontifax. “With the support of our outstanding group of investors, this financing positions us well to advance DYN101 through Phase 1/2 clinical evaluation in both adult and pediatric patients and expand our pipeline into other rare muscle disorders to strengthen Dynacure’s growth,” Stephane van Rooijen, Dynacure CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.